Healthy Clinical Trial
Official title:
Study of Thyrotropin Releasing Hormone in Patients With Thyroid or Pituitary Abnormalities
Verified date | April 2018 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will determine the safety and activity of a new formulation of
thyrotropin-releasing hormone (TRH), a drug used for diagnosing and evaluating patients with
certain thyroid gland abnormalities. Normal thyroid gland function depends on proper chemical
signaling between the thyroid gland, the hypothalamus (the part of the brain where TRH is
made), and the pituitary (another part of the brain). The TRH test helps assess this
interaction. Production of the only FDA-approved preparation of TRH was stopped in July 2002.
As a result, to have a continuous source of TRH available for NIH clinical and research
purposes, the NIH Clinical Center (CC) Pharmacy Department produced a pharmaceutical grade
formulation of TRH for patient use. This study will test the CC formulation in healthy
volunteers to show that its activity and side effects are similar to those of the previously
available commercial test preparation. It will then be studied in CC patients for whom the
diagnostic test is recommended.
Healthy volunteers between 18 and 65 years of age and all patients requiring TRH evaluation
of hypothalamic-pituitary-thyroid gland interaction may be eligible for this study. Patients
include those with pituitary reserve, inconsistent thyroid function test, inappropriate TSH
secretion, or pre- and post-operative evaluation of pituitary tumors. Normal volunteers will
be screened with a medical history, physical examination, and blood tests. Women of
child-bearing potential will be given a pregnancy test; pregnant and breast-feeding women may
not participate.
The TRH test procedure will be the same for healthy volunteers and patients. All participants
fast from midnight before the morning of the test. In the morning, a catheter (flexible
plastic tube) is inserted into an arm vein for easy injection of the TRH and collection of
blood samples. Blood pressure is monitored before and during the test. A blood sample is
drawn, and then TRH is given through the catheter over a 1-minute period. Another nine blood
samples are collected over a 3-hour period from the time of the TRH injection for measuring
levels of various hormones. A total of less than 4 tablespoons of blood is taken for the
test.
Status | Completed |
Enrollment | 96 |
Est. completion date | September 26, 2014 |
Est. primary completion date | September 26, 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 2 Years and older |
Eligibility |
- DIAGNOSTIC STUDY PROTOCOL Inclusion Criteria: -All adults and children requiring dynamic testing of the hypothalamic-pituitary axis for the evaluation of pituitary reserve, inconsistent thyroid function test, inappropriate TSH secretion, or pre-and post-operative evaluation of pituitary adenomas (glycoprotein hormone secreting tumors, growth hormone secreting tumors and TSH secreting tumors). Exclusion Criteria: - Uncontrolled hypertension; - Uncontrolled seizure disorder; - Unstable coronary disease; - Known allergy to TRH. RESEARCH PROTOCOLS -TRH is available for use in other IRB approved research protocols either using the standard diagnostic testing protocol or the modified TRH test. Exclusion Criteria: - Untreated hypertension; - Coronary artery disease; - History of asthma; - History of seizures; - Pregnancy; - Known allergy to TRH. |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
Faglia G. The clinical impact of the thyrotropin-releasing hormone test. Thyroid. 1998 Oct;8(10):903-8. Review. — View Citation
Haigler ED Jr, Pittman JA Jr, Hershman JM, Baugh CM. Direct evaluation of pituitary thyrotopin reserve utilizing synthetic thyrotopin releasing hormone. J Clin Endocrinol Metab. 1971 Oct;33(4):573-81. — View Citation
Jackson IM. Thyrotropin-releasing hormone. N Engl J Med. 1982 Jan 21;306(3):145-55. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | TSH Response to TRH | Serum TSH Levels in Response to TRH Administration | 180 minutes from infusion |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |